A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...

Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...

Minneapolis: According to a study, a class of diabetes medications may be linked to a decreased risk of dementia and Parkinson's disease. The findings were published in the online edition of ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Among the 358,862 participants with an average age of 58, a total of 6,837 people developed dementia or Parkinson's disease during the study. For Alzheimer's disease, the incidence rate for people ...

A specific type of diabetes medication has been associated with a lower risk of dementia, Alzheimer's and Parkinson's disease in a study published today. The South Korean study followed 358,862 ...